| P50 | author | David M. Holtzman | Q56827171 |
| | Anne M Fagan | Q66909797 |
| P2093 | author name string | D Schneider | |
| | C A Reardon | |
| | G Munson | |
| | G S Getz | |
| | J A Shah | |
| | J Lukens | |
| | L K Chang | |
| | M J LaDu | |
| | T Mathur | |
| P2860 | cites work | Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain | Q24309556 |
| | Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin | Q24320176 |
| | Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins | Q29547593 |
| | Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide | Q29977749 |
| | Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line | Q33848287 |
| | Apolipoproteins in human cerebrospinal fluid | Q33976139 |
| | Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3 | Q34229659 |
| | Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system | Q34559847 |
| | Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease | Q34662682 |
| | Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease | Q34729047 |
| | Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration | Q35150586 |
| | Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection | Q36070257 |
| | Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers | Q37633630 |
| | Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets | Q37672903 |
| | Biology of A beta amyloid in Alzheimer's disease | Q39115574 |
| | Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins | Q40144506 |
| | Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). | Q40643050 |
| | Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease | Q40849918 |
| | Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein | Q41150323 |
| | Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. | Q41664894 |
| | Apolipoprotein J: structure and tissue distribution | Q41731295 |
| | The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex | Q42161240 |
| | A new low density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse | Q42632060 |
| | Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function? | Q42990179 |
| | Lipoprotein-receptor interactions | Q43868984 |
| | Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro | Q45081026 |
| | Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress | Q46021433 |
| | Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen. | Q46030268 |
| | Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta | Q46256650 |
| | Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro | Q46296108 |
| | Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain | Q46420644 |
| | Purification and characterization of brain clusterin | Q46450250 |
| | Seizure activity causes a rapid increase in sulfated glycoprotein-2 messenger RNA in the adult but not the neonatal rat brain | Q46484434 |
| | Astrocytic messenger RNA responses to striatal deafferentation in male rat. | Q46505757 |
| | Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins | Q46656933 |
| | Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition | Q48601482 |
| | Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning | Q48668350 |
| | Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease | Q48795523 |
| | Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease. | Q49023125 |
| | SP-40,40 is a constituent of Alzheimer's amyloid | Q53179261 |
| | Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments | Q59053832 |
| | Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins | Q68921833 |
| | Electron microscopy of negatively stained lipoproteins | Q68966662 |
| | Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions | Q70478363 |
| | Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins | Q71209926 |
| | Expression of apolipoprotein E mRNA in rat microglia | Q71538993 |
| | Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides | Q71727345 |
| | Characterization of apolipoprotein J-Alzheimer's A beta interaction | Q72132225 |
| | Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid | Q72167723 |
| | The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma | Q72362862 |
| | Phospholipid transfer protein can transform reconstituted discoidal HDL into vesicular structures | Q74061182 |
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| | astrocyte | Q502961 |
| P304 | page(s) | 30001-30007 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice | |
| P478 | volume | 274 | |